Siemens Healthineers stock sits 23.21 percent below its yearly high

Published on 10/08/2026 at 12:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Siemens Healthineers stock costs EUR 38.17 on October 8, 2026 versus EUR 38.50. It is 23.21 percent below its yearly high.

Isometrische Illustration einer Diagnostik-Prozesskette mit Scanner und Labor — Siemens Healthineers DE000SHL1006 visualisiert isometrische Diagnostik-Wertschöpfungskette von Scanner über Labor bis Arztauswertung, Illustration mit AI erstellt.

Siemens Healthineers (DE000SHL1006) was trading at EUR 38.17 at Lang & Schwarz on October 8, 2026 at 12:07 p.m. CEST, placing the stock 23.21 percent below its 52-week high of EUR 49.71. The company picture combines solid quarterly revenue with a lower growth outlook for fiscal 2026.

Revenue reached EUR 5.764 billion

In the third quarter of fiscal 2026, revenue reached EUR 5.764 billion, an increase of 1.80 percent from EUR 5.662 billion in the prior-year quarter, according to Yahoo Finance. The same fiscal-quarter materials said the equipment book-to-bill ratio reached 1.27, while Precision Therapy grew 9.00 percent.

The comparison is uneven across divisions. Diagnostics remained pressured by the structural market reset in China, while the company described Imaging revenue shifts into the fourth quarter as temporary in the fiscal third-quarter call.

Guidance reflects Diagnostics pressure

Management lowered fiscal 2026 revenue growth guidance from 4.50-5.00 percent to 3.50-4.00 percent, citing Diagnostics weakness. At the same time, adjusted earnings per share guidance rose by EUR 0.15 at both ends to EUR 2.35-2.45 because of tariff refunds, according to the fiscal 2026 earnings-call transcript published by Yahoo Finance. That distinction matters: the lower revenue range reflects an operating issue, while the higher earnings range includes a one-off benefit.

Siemens Healthineers also continued its share buyback. EQS News reported on October 5, 2026 that 49,987 shares had been repurchased between September 28 and October 4, bringing the program total since June 1 to 3,424,346 shares.

Deutsche Bank keeps a Hold rating

For the coming results, Deutsche Bank Research maintained a Hold rating and a EUR 39.00 price target on October 5, 2026. The bank forecast 6.00 percent organic revenue growth but warned that profitability could be weak, as reported by finanzen.net.

Stock stays below the yearly high

The next scheduled results date is November 5, 2026, when Siemens Healthineers is due to report fiscal fourth-quarter figures and hold its analyst call, according to the company's investor-relations calendar. The current valuation leaves EUR 11.54 between the Lang & Schwarz price and the 52-week high, while the prior close was EUR 38.50.

At Lang & Schwarz, Siemens Healthineers was trading at EUR 38.17 on October 8, 2026 at 12:07 p.m. CEST, down EUR 0.33 or minus 0.86 percent versus the prior close of EUR 38.50. The further course of trading is shown by the continuously updated real-time quote of Siemens Healthineers stock.